MERS-CoV and Its Impact in the Middle East/Arab World

Banik, G; Kok, J; Rashid, H

MERS-CoV and Its Impact in the Middle East/Arab World

Banik, G Kok, J Rashid, H

Permalink

Publisher:: Springer
Publication Type:: Chapter
Citation:: Handbook of Healthcare in the Arab World, 2021, pp. 2993-3005
Issue Date:: 2021

Closed Access

	Filename	Description	Size
	Banik2020_ReferenceWorkEntry_MERS-CoVAndItsImpactInTheMiddl.pdf	Published version	293.81 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Banik, G
dc.contributor.author	Kok, J
dc.contributor.author	Rashid, H
dc.date.accessioned	2022-05-14T20:54:21Z
dc.date.available	2022-05-14T20:54:21Z
dc.date.issued	2021
dc.identifier.citation	Handbook of Healthcare in the Arab World, 2021, pp. 2993-3005
dc.identifier.isbn	978-3-030-36810-4
dc.identifier.uri	http://hdl.handle.net/10453/157354
dc.description.abstract	Middle East respiratory syndrome coronavirus (MERS-CoV) that causes a severe lower respiratory tract infection in humans is considered a pandemic threat to the Gulf region. In this chapter, the latest information on MERS-CoV biology, epidemiology, transmission dynamics, clinical features, diagnosis, treatment, and preventive strategy are summarized. The current epidemiology is characterized by slow and sustained transmission with occasional sparks in the Middle East. Although the transmission cycle of MERS-CoV is not fully understood yet, the dromedary camel is considered to be the intermediate host of the virus and believed to play an important role in the epidemiology of the virus. MERS-CoV is particularly severe in men with comorbidities and rare in children. Several vaccine approaches have shown efficacy in animal models and begun to enter clinical trials. Travellers to the Middle East may benefit from health education on avoidance of exposure to camels and ill persons and refraining from consuming raw camel products.
dc.format.extent	154
dc.language	en
dc.publisher	Springer
dc.relation.ispartof	Handbook of Healthcare in the Arab World
dc.relation.isbasedon	10.1007/978-3-030-36811-1_134
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	MERS-CoV and Its Impact in the Middle East/Arab World
dc.type	Chapter
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2022-05-14T20:54:20Z
pubs.place-of-publication	Switzerland
pubs.publication-status	Published
dc.location	Switzerland

Abstract:

Middle East respiratory syndrome coronavirus (MERS-CoV) that causes a severe lower respiratory tract infection in humans is considered a pandemic threat to the Gulf region. In this chapter, the latest information on MERS-CoV biology, epidemiology, transmission dynamics, clinical features, diagnosis, treatment, and preventive strategy are summarized. The current epidemiology is characterized by slow and sustained transmission with occasional sparks in the Middle East. Although the transmission cycle of MERS-CoV is not fully understood yet, the dromedary camel is considered to be the intermediate host of the virus and believed to play an important role in the epidemiology of the virus. MERS-CoV is particularly severe in men with comorbidities and rare in children. Several vaccine approaches have shown efficacy in animal models and begun to enter clinical trials. Travellers to the Middle East may benefit from health education on avoidance of exposure to camels and ill persons and refraining from consuming raw camel products.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/157354